This National Institutes of Health (NIH) grant is dedicated to accelerating the development of innovative device-based treatments for Substance Use Disorders (SUDs). Leveraging rapid advancements in technology, this funding opportunity seeks proposals for novel neuromodulatory or neurophysiological devices that demonstrate potential as safe and effective interventions for SUDs. The primary objective is to propel promising device candidates through critical stages of the U.S. Food and Drug Administration (FDA) approval pathway. Ultimately, the grant aims to foster the creation of a new generation of FDA-approved medical devices, expanding therapeutic options available for individuals struggling with substance use disorders and improving patient outcomes. This represents a strategic investment in innovative biotechnological solutions to address a critical public health challenge.
Opportunity ID: 328377
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-279 |
| Funding Opportunity Title: | Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.273 — Alcohol Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 27, 2020 |
| Last Updated Date: | Jul 27, 2020 |
| Original Closing Date for Applications: | Aug 10, 2023 |
| Current Closing Date for Applications: | Aug 10, 2023 |
| Archive Date: | Sep 15, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Public and State controlled institutions of higher education County governments Small businesses City or township governments For profit organizations other than small businesses Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Public housing authorities/Indian housing authorities Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of devices to treat Substance Use Disorders (SUDs). The continuing advances in technologies offer unprecedented opportunities to develop neuromodulatory or neurophysiological devices that are safe and effective SUD treatments. The objective is to move devices to their next step in the FDA approval process, with the ultimate goal of generating new, FDA approved device-based treatments for SUDs. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-279.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 328377 Full Announcement-PAR-20-279 -> PAR-20-279-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00262787 | Nov 15, 2020 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270458 | Nov 18, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278419 | Nov 15, 2022 | Aug 10, 2023 | View |
Package 1
Mandatory forms
328377 RR_SF424_2_0-2.0.pdf
328377 PHS398_CoverPageSupplement_5_0-5.0.pdf
328377 RR_OtherProjectInfo_1_4-1.4.pdf
328377 PerformanceSite_2_0-2.0.pdf
328377 RR_KeyPersonExpanded_2_0-2.0.pdf
328377 RR_Budget_1_4-1.4.pdf
328377 PHS398_ResearchPlan_4_0-4.0.pdf
328377 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
328377 RR_SubawardBudget30_1_4-1.4.pdf
328377 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
328377 RR_SF424_5_0-5.0.pdf
328377 PHS398_CoverPageSupplement_5_0-5.0.pdf
328377 RR_OtherProjectInfo_1_4-1.4.pdf
328377 PerformanceSite_4_0-4.0.pdf
328377 RR_KeyPersonExpanded_4_0-4.0.pdf
328377 RR_Budget_3_0-3.0.pdf
328377 PHS398_ResearchPlan_4_0-4.0.pdf
328377 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
328377 RR_SubawardBudget30_3_0-3.0.pdf
328377 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
328377 RR_SF424_5_0-5.0.pdf
328377 PHS398_CoverPageSupplement_5_0-5.0.pdf
328377 RR_OtherProjectInfo_1_4-1.4.pdf
328377 PerformanceSite_4_0-4.0.pdf
328377 RR_KeyPersonExpanded_4_0-4.0.pdf
328377 RR_Budget_3_0-3.0.pdf
328377 PHS398_ResearchPlan_5_0-5.0.pdf
328377 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
328377 RR_SubawardBudget30_3_0-3.0.pdf
328377 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
